Page last updated: 2024-10-20

pyridoxine and Raynaud Disease

pyridoxine has been researched along with Raynaud Disease in 2 studies

4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).

Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ROBERT D'ESHOUGUES, J1
GILLE, C1
BIANCHI, M1
DELACROIX, J1
Kim, M1

Other Studies

2 other studies available for pyridoxine and Raynaud Disease

ArticleYear
[Pyridoxin in the treatment of Raynaud's disease].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1962, Mar-14, Volume: 38

    Topics: Humans; Pyridoxine; Raynaud Disease; Vitamin B 6

1962
[Drugs in syndromes of dysfunction of arteriovenous anastomoses].
    Angeiologie, 1967, Volume: 20

    Topics: Acetylcholine; Animals; Arteriovenous Anastomosis; Epinephrine; Ergoloid Mesylates; Histamine; Human

1967